Tourmaline Bio Inc
NASDAQ:TRML
Balance Sheet
Balance Sheet Decomposition
Tourmaline Bio Inc
Tourmaline Bio Inc
Balance Sheet
Tourmaline Bio Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
39
|
18
|
19
|
14
|
141
|
31
|
|
| Cash Equivalents |
39
|
18
|
19
|
14
|
141
|
31
|
|
| Short-Term Investments |
0
|
132
|
225
|
168
|
62
|
228
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
2
|
1
|
3
|
4
|
6
|
11
|
|
| Total Current Assets |
41
|
151
|
247
|
186
|
209
|
269
|
|
| PP&E Net |
1
|
2
|
5
|
8
|
1
|
0
|
|
| PP&E Gross |
1
|
2
|
5
|
8
|
1
|
0
|
|
| Accumulated Depreciation |
2
|
2
|
3
|
4
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
37
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
3
|
|
| Total Assets |
42
N/A
|
153
+265%
|
251
+65%
|
194
-23%
|
210
+8%
|
309
+47%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
1
|
3
|
4
|
1
|
4
|
|
| Accrued Liabilities |
1
|
2
|
5
|
8
|
4
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
8
|
12
|
5
|
9
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
1
|
2
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
5
+100%
|
9
+79%
|
14
+59%
|
5
-62%
|
9
+70%
|
|
| Equity | |||||||
| Common Stock |
57
|
186
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
20
|
43
|
91
|
165
|
62
|
135
|
|
| Additional Paid In Capital |
3
|
5
|
334
|
346
|
267
|
435
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
40
N/A
|
148
+274%
|
243
+64%
|
180
-26%
|
205
+14%
|
300
+46%
|
|
| Total Liabilities & Equity |
42
N/A
|
153
+265%
|
251
+65%
|
194
-23%
|
210
+8%
|
309
+47%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
4
|
4
|
5
|
4
|
20
|
26
|
|